A Promising New Strategy for Treating Triple-Negative Breast Cancer
Brigham and Women’s Hospital Research Briefs | October 9, 2024
Published in Nature - research led by Karen Cichowski’s lab in collaboration with several LSP members (including Yilin Xu, Jia-Ren Lin, Peter Sorger, and Sandro Santagata) suggests that combined treatment with AKT and EZH2 inhibitors kills TNBC cells more effectively in in vivo models. This work could provide a promising new therapeutic strategy for treating TNBC.
Latest News
October 30, 2025
3D Imaging Maps the Hidden Landscape of Human Tumors
November 4, 2025
Tumor Sight Selected as Biomedical Picture of the Day
October 29, 2025
Paper Talk Podcast – Highly Multiplexed 3D Tumor Profiling
October 15, 2025
Kristin Qian presents work in spatial profiling at European Society for Spatial Biology conference
